Teens with bipolar or schizophrenia get long-term safety check for OLZ/SAM
Disease control
ENROLLING_BY_INVITATION
This study looks at the long-term safety of a drug called OLZ/SAM in teenagers with schizophrenia or bipolar I disorder. About 236 teens who finished a previous study can join. Researchers will track side effects over time to see if the drug is safe for ongoing use.
Phase: PHASE3 • Sponsor: Alkermes, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC